Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression
Carlota Tuero(Clinica Universidad de Navarra), Amaia Rodrı́guez(Instituto de Salud Carlos III), Gabriela Neira(Instituto de Salud Carlos III), Gema Frühbeck(Clinica Universidad de Navarra), Sara Becerril(Instituto de Salud Carlos III), Silvia Ezquerro(Instituto de Salud Carlos III)
Cited by 10
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations
|Diabetes Care|2016|969
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
|Diabetologia|2024|150
Ghrelin reduces TNF-α-induced human hepatocyte apoptosis, autophagy and pyroptosis: role in obesity-associated NAFLD
|The Journal of Clinical Endocrinology & Metabolism|2018|110